Skip to content
logic-logo

tagline-header

Search
Close
Login Subscribe
Welcome,
  • My Account
  • Log Out

Leaders are born in times of crisis

By entering your e-mail you consent to receiving commercial electronic messages from The Logic Inc. containing news, updates, offers or promotions about The Logic Inc.’s products and services. You can withdraw your consent at anytime. Please refer to our privacy policy or contact us for more details.

Vancouver’s Notch Therapeutics raises US$85 million as biotech rush continues

By Aleksandra Sagan

Big Tech podcast: Ellen Jorgensen on biotech’s potential and the complexities of regulation

By The Logic

Hamilton, Ont.-based biotech firm set to go public in the U.S.

By Catherine McIntyre

Quebec biotech sector sees $150-million investment

By Martin Patriquin

Amplitude Venture Capital launches $200-million biotech fund focused on Canadian firms

By Zane Schwartz

Federal Budget 2021: Ten key takeaways for the innovation economy

By Murad Hemmadi, Catherine McIntyre, Claire Brownell and Martin Patriquin

U.S. to buy new combo version of AbCellera, Eli Lilly COVID-19 treatment in revised deal

By Aleksandra Sagan

‘It is very personal’: AbCellera’s COVID-19 treatment is saving lives in the U.S. In Canada, it’s sitting in storage. Now the company’s CEO is speaking out

By Aleksandra Sagan

AbCellera reports 2020 profit after US$2M loss in 2019

By Aleksandra Sagan
Then-foreign affairs minister Francois-Philippe Champagne in the House of Commons in Ottawa in November, 2020.

Ottawa signals focus on data, AI, critical minerals in national security reviews of foreign investment

By Murad Hemmadi

Posts navigation

Older posts
tagline-footer

The Logic © 2021 The Logic Inc. All Rights Reserved.

  • About Us
  • Terms
  • Privacy Policy
  • Contact Us
Login

or

Facebook
Google
Twitter
LinkedIn
Login with password
I don’t have an account

Create Account

Facebook
Google
Twitter
LinkedIn
I do have an account